FdaApplication
NDA 212099
Identifiers
- fda_app_no: NDA212099
Properties
| Property | Value |
|---|---|
| applicant_name | BAYER HEALTHCARE PHARMACEUTICALS INC |
| application_type | NDA |
| approval_date | 2019-07-30 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| NUBEQA | DAROLUTAMIDE | 300MG | TABLET;ORAL |
1 product